The diagnostic enzymes market is expanding steadily as healthcare systems increasingly rely on accurate laboratory testing for early disease detection, clinical decision-making, and personalized patient care. Diagnostic enzymes are essential components of in vitro diagnostic assays, supporting biochemical analysis, molecular diagnostics, immunoassays, and clinical chemistry testing. Growing...

The electrophoresis reagents market is experiencing steady growth as molecular biology, genomics, proteomics, and clinical diagnostics continue to expand across research and healthcare sectors. Electrophoresis remains a fundamental laboratory technique for separating DNA, RNA, and proteins, making high-quality reagents essential for accurate analytical results. Growing investments in life...

The global GMP testing service market is experiencing strong expansion due to the increasing emphasis on regulatory compliance, rising pharmaceutical manufacturing activities, and growing demand for high-quality drug products. Good Manufacturing Practice (GMP) testing services play a critical role in ensuring that pharmaceutical, biotechnology, and medical device products meet stringent safety,...

According to a newly published market research report by 24LifeSciences, global head and neck cancer diagnostics market was valued at USD 1.85 billion in 2024 and is projected to reach USD 3.47 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.1% during the forecast period 20252032. Head and neck cancer diagnostics encompass a sophisticated array of imaging...

The lymphoma treatment market is experiencing steady growth as advances in oncology research continue to improve the diagnosis and management of lymphoma. Increasing awareness of hematologic cancers, expanding access to specialized cancer care, and the development of innovative treatment approaches are driving market expansion worldwide. Healthcare providers are increasingly adopting targeted...

The global microbial identification methods market is witnessing significant growth due to the increasing demand for rapid and accurate microbial detection across healthcare, pharmaceuticals, food safety, environmental testing, and biotechnology industries. Microbial identification techniques play a critical role in identifying bacteria, fungi, viruses, and other microorganisms to support...

The Middle East cancer targeted therapy market is witnessing substantial growth due to the increasing prevalence of cancer and the growing adoption of precision medicine across healthcare systems in the region. The Middle East Cancer Targeted Therapy Market size is expected to reach US$ 2,163.7 million by 2031 from US$ 1,051.4 million in 2024. The market is estimated to record a CAGR of 10.9%...

Sexually transmitted infections continue to represent a major public health challenge across the world, creating substantial demand for accurate, rapid, and accessible diagnostic solutions. Rising awareness regarding early disease detection, increasing prevalence of sexually transmitted infections, and expanding government screening initiatives are significantly contributing to the growth of...

According to a newly published market research report by 24LifeSciences, the global thyroid cancer testing market was valued at USD 1.63 billion in 2024 and is projected to reach USD 2.84 billion by 2031, growing at a compound annual growth rate (CAGR) of 7.3% during the forecast period 2025–2031. Thyroid cancer testing encompasses a comprehensive suite of diagnostic procedures essential...

The United States is a major market for cell lysis technologies, supported by extensive investments in biotechnology, pharmaceutical research, and molecular diagnostics. The presence of leading life science companies, advanced research institutions, and a strong focus on genomics and proteomics research continues to drive demand for efficient cell lysis solutions. Additionally, growing adoption...